Lite Strategy, Inc. (LITS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.6x

Market Cap

$38.79M

MomentumView details →

1D Return

+9.62%

YTD Return

−20.08%

RSI (14)

62.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.6x

Market Cap

$38.79M

RSI (14)

62.9

MomentumView details →

1D Return

+9.62%

YTD Return

−20.08%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−107.01%

ROA (TTM)

−105.24%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

−92.21%

FCF YoY

—

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

—

EBITDA YoY

+62.35%

EarningsView details →

EPS (Actual)

−$0.66

EPS Surprise

78.82%

Beats (12Q)

4/12

Next Q EPS Est

−$3.37

Avg Surprise (4Q)

43.10%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

11.53x

Quick Ratio

11.53x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−60.82M

Op. CF (TTM)

−10.42M

Next earningsSep 28, 2026 →

Latest newsMore news →

Lite Strategy repurchased approximately 4.9 million shares of its common stock, or 13% of outstanding shares, since December 2025 through July 17, 2026.36d ago

Similar companies

Aligos Therapeutics, Inc.ALGS CervoMed Inc.CRVO Quantum-Si incorporatedQSIAW Filana Therapeutics, Inc.FLNA Mereo BioPharma Group plcMREO Karyopharm Therapeutics Inc.KPTI Find similar companies →

Latest newsMore news →

Lite Strategy repurchased approximately 4.9 million shares of its common stock, or 13% of outstanding shares, since December 2025 through July 17, 2026.36d ago